Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ginsberg

Showing results (551-560 of 607) with videos related to

Pageof 61
Sort By:
Journal of Thrombosis and Haemostasis : JTH|April 30, 2019
Long-term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d-dimer results; A cohort studyClive Kearon, Sameer Parpia, Frederick A Spencer, et al.
The Journal of Arthroplasty|June 7, 2008
Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery, Jeffrey S Ginsberg, Bruce L Davidson, et al.
The Journal of Infectious Diseases|July 4, 1998
First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host responseR R MacGregor, J D Boyer, K E Ugen, et al.
The Lancet. Oncology|November 10, 2016
Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trialAlexander Drilon, Natasha Rekhtman, Maria Arcila, et al.
Molecular Phylogenetics and Evolution|January 2, 2021
A phylogeny for the Drosophila montium species group: A model clade for comparative analysesWilliam R Conner, Emily K Delaney, Michael J Bronski, et al.
Journal of Thrombosis and Haemostasis : JTH|March 1, 2005
Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosisS R Kahn, C Kearon, J A Julian, et al.
The Annals of Pharmacotherapy|March 17, 2005
Influence of warfarin on symptoms of fatigue: findings of a randomized trialMichael J Kovacs, Clive Kearon, Jim A Julian, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 12, 2016
Phase II Study of a Non-Platinum-Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung AdenocarcinomasM C Pietanza, Matthew D Hellmann, John J Fiore, et al.
Haematologica|April 19, 2012
Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excludedRenée A Douma, Melanie Tan, Roger E G Schutgens, et al.
The New England Journal of Medicine|September 19, 2003
A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndromeMark A Crowther, Jeff S Ginsberg, Jim Julian, et al.
Pageof 61

Showing results (551-560 of 607) with videos related to

Sort By:
Pageof 61
Journal of Thrombosis and Haemostasis : JTH|April 30, 2019
Long-term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d-dimer results; A cohort studyClive Kearon, Sameer Parpia, Frederick A Spencer, et al.
The Journal of Arthroplasty|June 7, 2008
Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery, Jeffrey S Ginsberg, Bruce L Davidson, et al.
The Journal of Infectious Diseases|July 4, 1998
First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host responseR R MacGregor, J D Boyer, K E Ugen, et al.
The Lancet. Oncology|November 10, 2016
Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trialAlexander Drilon, Natasha Rekhtman, Maria Arcila, et al.
Molecular Phylogenetics and Evolution|January 2, 2021
A phylogeny for the Drosophila montium species group: A model clade for comparative analysesWilliam R Conner, Emily K Delaney, Michael J Bronski, et al.
Journal of Thrombosis and Haemostasis : JTH|March 1, 2005
Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosisS R Kahn, C Kearon, J A Julian, et al.
The Annals of Pharmacotherapy|March 17, 2005
Influence of warfarin on symptoms of fatigue: findings of a randomized trialMichael J Kovacs, Clive Kearon, Jim A Julian, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 12, 2016
Phase II Study of a Non-Platinum-Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung AdenocarcinomasM C Pietanza, Matthew D Hellmann, John J Fiore, et al.
Haematologica|April 19, 2012
Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excludedRenée A Douma, Melanie Tan, Roger E G Schutgens, et al.
The New England Journal of Medicine|September 19, 2003
A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndromeMark A Crowther, Jeff S Ginsberg, Jim Julian, et al.
Pageof 61